tiprankstipranks
Aktis Oncology, Inc. (AKTS)
NASDAQ:AKTS
US Market
AKTS
Aktis Oncology, Inc.
RESEARCH TOOLSreports
Want to see AKTS full AI Analyst Report?

Aktis Oncology, Inc. (AKTS) Financial Statements

27 Followers

Aktis Oncology, Inc. Financial Overview

Aktis Oncology, Inc.'s market cap is currently $1.33B. The company's EPS TTM is $; its P/E ratio is -29.25; Aktis Oncology, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 6.50M$ 1.49M$ 0.00$ 0.00
Gross Profit$ 6.50M$ 1.49M$ 0.00$ 0.00
Operating Income$ -74.68M$ -52.05M$ -34.79M$ -19.76M
EBITDA$ -61.40M$ -42.41M$ -27.45M$ -17.48M
Net Income$ -63.73M$ -43.98M$ -28.64M$ -17.93M
Balance Sheet
Cash & Short-Term Investments$ 226.79M$ 297.17M$ 97.86M$ 128.60M
Total Assets$ 264.88M$ 326.18M$ 122.36M$ 138.32M
Total Debt$ 11.55M$ 12.01M$ 13.40M$ 1.77M
Net Debt$ -26.24M$ -25.15M$ -16.11M$ -126.82M
Total Liabilities$ 411.03M$ 413.98M$ 168.66M$ 157.55M
Stockholders' Equity$ -146.15M$ -87.80M$ -46.31M$ -19.23M
Cash Flow
Free Cash Flow$ -73.71M$ 11.90M$ -33.77M$ -20.43M
Operating Cash Flow$ -64.13M$ 14.76M$ -30.00M$ -18.13M
Investing Cash Flow$ 65.96M$ -190.40M$ -68.83M$ -2.31M
Financing Cash Flow$ -1.21M$ 183.28M$ 0.00$ 119.98M
Currency in USD

Aktis Oncology, Inc. Earnings and Revenue History

Income Statement >

Aktis Oncology, Inc. Debt to Assets

Balance Sheet >

Aktis Oncology, Inc. Cash Flow

Cash Flow >

Aktis Oncology, Inc. Forecast EPS vs Actual EPS

Earnings >